InvestorsHub Logo

oakrock

11/17/18 2:47 AM

#86189 RE: gbrown6332 #86188

I bought 55,000 Shares this morning between .45 and .47. I feel good about it. Science wise, we have never had really bad news. Cash and spending has been our issue. Ken now has grip on his budgets and now needs to put his marketing hat on.

There is a lot of money out there from this bull market that make be looking for interest. Lm Tech!!

A Proprietary Antigen Delivery Platform that Activates the Immune System, Naturally

Lm Technology represents an advancement in the field of immunotherapy, as its comprehensive immune stimulation and priming redirects a “pathogen-like” response against cancers. The Lm Technology vector, the basis of each of our products, is designed to stimulate multiple immunotherapy mechanisms. When compared to traditional cancer treatments such as chemotherapies, Lm Technology product candidates are generally well-tolerated, with mild to moderate, transient adverse events. Importantly, Advaxis’ product candidates have the potential for combination with conventional and novel therapies, including other immunotherapy products that modulate the immune response, such as checkpoint inhibitors, co-stimulatory agents, radiation therapy, and other active cancer therapies.